反応 #68047

ord-473148dd016b4c6ba71b60824cefb0a1

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    workup.ADDITIONwas added
  2. 2
    その他The solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform
  3. 3
    workup.ADDITIONwere added
  4. 4
    その他The organic layer was separated
  5. 5
    抽出the aqueous layer was extracted with chloroform
  6. 6
    洗浄washed with aqueous saturated sodium chloride solution
  7. 7
    乾燥dried over anhydrous magnesium sulfate
  8. 8
    その他the solvent was removed under reduced pressure
  9. 9
    その他The residue thus obtained
  10. 10
    その他was purified by silica gel column chromatography [eluent; chloroform:methanol=10:1]

実験手順

To 2 mL of a chloroform solution containing 0.25 g of methyl 1-(2-(4-((tert-butoxycarbonyl)(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate, 2 mL of trifluoroacetic acid was added and stirred for 16 hours. The solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform were added. The organic layer was separated, and the aqueous layer was extracted with chloroform. The organic layer and extracts were combined, washed with aqueous saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue thus obtained was purified by silica gel column chromatography [eluent; chloroform:methanol=10:1] to give 0.12 g of methyl 1-(2-(4-((2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate as a white solid.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US08524738B2uspto-grants-2013_09